CD274 and neoplasm: In the Post-1L IO (n = 350) population with a known tumour PD-L1 expression status, a total of 84 (24.0%) and 110 (31.4%) patients had a tumour proportion score (TPS) ≥50% and 1% ≤ TPS ≤ 49%, respectively.